학술논문
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Document Type
Article
Author
Source
In: Frontiers in Pharmacology . (Frontiers in Pharmacology, 2023, 14)
Subject
Language
English
ISSN
16639812